TP53 and cancer: Sometimes, ribozymes recognize cancer biomarkers, such as mutant p53 protein or human telomerase reverse transcriptase (hTERT) mRNA, and then activate cancer-killing genes, such as diphtheria toxin (DT) or herpes simplex virus thymidine kinase (HSVtk), that are delivered together to kill cancer cells directly [96,97].